Full Answer
STATUS OF REMICADE LAWSUITS: Lawyers are evaluating research surrounding the potential safety concerns involving cancer and Remicade, as well as potential cases for individuals who developed fungal infections.
Other cancers reported included leukemia, melanoma and solid organ cancers. REMICADE FUNGAL INFECTIONS: A number of users who were receiving TNF blockers, such as Remicade, have experienced fungal infections, such as histoplasmosis, blastomycosis and cocciioidmycosis. In several of these cases the infection resulted in death.
OVERVIEW: Remicade (infliximab) is an autoimmune disorder drug known as a Tumor Necrosis Factor (TNF) Blocker. It is approved by the FDA for treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis.
Over 2.8 million patients have been prescribed REMICADE® worldwide*
Remicade can increase your risk of serious infections that may lead to hospitalization or death. This drug affects your immune system. It can decrease your body's ability to fight infections such as tuberculosis or infections caused by different bacteria, viruses, fungi, or parasites.
The settlement, filed in a federal court in the Eastern District of Pennsylvania, is intended to resolve class-action claims against the company for its alleged obstruction of insurers covering generic versions of Remicade, which is a tumor necrosis-factor blocking drug.
Patients treated with REMICADE® (infliximab) are at increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.
The drug is a purified form of recombinant DNA-derived human-mouse monoclonal antibodies consisting of mouse and human's heavy and light chain variable regions.
It's used to treat moderate to severe Crohn's disease. It was initially designed as a chemotherapy drug to treat cancer but wasn't effective for cancer. The drug has been shown to work against autoimmune diseases like rheumatoid arthritis and Crohn's.
Humira, Remicade Side Effects Linked To Increased Peripheral Neuropathy Risk: Study. The findings of a new study suggest the side effects of Humira, Remicade and similar rheumatoid arthritis drugs may increase the risk of a form of nerve damage, known as peripheral neuropathy.
The European Medicines Agency's database of Adverse Drug Reactions contains 23 reported incidents of Parkinson's disease with eight reported as 'not recovered/not resolved' and 15 'unknown', concerning Remicade.
1 REMICADE® is a U.S. registered trademark of Janssen Biotech, Inc.
Higher levels of these antibodies were associated with a much shorter response to treatment -- an average of 35 days compared with 71 days for patients who had lower antibody levels.
Doctors use a drug's half-life to find out how long the drug stays in your blood. Usually after about 4 to 5 half-lives, your body will have rid itself of the medication. It takes between 7 to 9 days for the body to get rid of half of a dose of Remicade. This means Remicade can stay in your system for 28 to 45 days.
You may also be given a single dose of an IV steroid, Benadryl and/or Tylenol to prevent this type of reaction. The steroid also helps to enhance the response you will get from the Infliximab. Infusion reactions may also occur and will do so within 2 hours after the infusion.
Remicade is an injectable drug used to relieve the symptoms of certain autoimmune disorders including:
The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).
If you or a loved one has been injured as a result of taking Remicade, contact our attorneys today to schedule a free consultation; you may be entitled to compensation, and we believe that all injured parties deserve to extract just recompense from those who cause undue harm and suffering.
Reglan side effects include, but are not limited to the following: Occasionally Fatal Blood Disorders. Infection. Lymphoma and Other Solid Tissue Cancers.
Remicade, also known as Infliximab, is an immunosuppressant, multi-use drug.
Hiring a settlement broker can give you the best chance of success. The RIM settlement broker will do all the legwork for you. He will contact the insurance company and try to negotiate a reasonable settlement. If you’re represented by a professional, experienced lawyer, he will also be able to handle the paperwork involved.
Take the time to check them out and see if you can find a company near you that will help you with your case. It will be well worth the effort, because it could help you receive the money you deserve. So if you have been the victim of someone’s negligence or wrongdoing, contact a personal injury attorney and see what he can do for you. They will be able to help you through the claims process and provide advice on your particular case.
It was a RIM settlement that getting a good settlement because they were able to limit the claims that could be made. When there are too many details that need to be checked and documented, it takes more time. By sticking to the basics, such as doctor visits, lost wages, pain and suffering, the company saved itself a lot of time and money.
He knows the details of the victim and his family and how they have been affected. The broker has a vested interest in seeing that you get the maximum amount for your pain and suffering and medical bills.
Sometimes it’s possible to bring a case before the Merger Panel and make it to a trial. The key is to have a good defense to bring. Even if you think you have a strong case, some insurance companies will fight tooth and nail to make sure you don’t get paid. Having a good defense will make your life much easier.
In fact, they deal with more than just injured workers. If the case involves an employer or company, the claim is likely to be different. Claims involving weather and injuries will be different than claims involving death or illness. The company will try to fight you in court and try to limit any compensation that you receive. If you’re not represented by a professional lawyer, you stand a good chance of losing your case.
The news that RIM has settled the lawsuits brought against them by injured workers is being heralded with both praise and alarm. This is because the settlements amount to very less than the billions of dollars that RIM has to pay out over the next decade. In addition, it is a loss for the company that has been on its knees for the last two years since the accident. The settlement broker who arranged the RIM’s settlement will make sure that you do not lose anything. They will also advise you about how to best present your case to the insurance adjuster.
Remicade is manufactured by Centocor and distributed by Johnson & Johnson and is used to treat rheumatoid arthritis and Crohn’s disease. The FDA has been told of 580 adverse reaction reports among 509,000 worldwide patients, said Craig Buchholz, a Centocor spokesman. Forty-four reports were most worrisome because they involved significant blood disorders. At least 12 patients taking Remicade in combination with other drugs died worldwide.
Remicade (Infliximab), an immune-suppressing drug used to treat rheumatoid arthritis and Crohn’s disease, is reported to be responsible for 70 reported cases of tuberculosis (TB) among US patients. The cases, at least four of which were fatal, were reported to the Food and Drug Administration between 1998 and May of this year. Researchers who reviewed the cases say that the immune-system protein infliximab suppresses called tumor necrosis factor alpha (TNF-alpha) appears to be key in controlling TB infection.
Around 150,000 people worldwide have received Infliximab infusions since the drug’s approval in 1998. Pennsylvania-based Centocor, which announced it was changing the drug’s prescribing information to address the TB concerns. The revised labeling states that patients should be tested and treated for inactive, or latent, TB prior to Infliximab therapy. Latent TB refers to a chronic, but symptom less and noncontiguous, infection. Such TB infections are prevalent throughout the world because in most people, the immune system is able to suppress TB bacteria.
Parker Waichman LLP is no longer accepting new cases for this litigation as the litigation has either resolved or the statute of limitation has expired for the defects we were investigating. However, if you bought this product or a similar product within the last three years and are experiencing issues, click here to listen to a message from our founding partner, attorney Jerry Parker.
Remicade May Cause Blood Disorders. Patients taking Remicade (Generic: Infliximab) for rheumatoid arthritis suffered a type of cancer, lymphoma, at three times the rate of the general public, manufacturer Centocor warned. Centocor, a subsidiary of Johnson & Johnson, said the lymphoma incidence rate was six times higher among all patients who took the monoclonal antibody in completed clinical trials.
Other cancers reported included leukemia, melanoma and solid organ cancers. REMICADE FUNGAL INFECTIONS: A number of users who were receiving TNF blockers, such as Remicade, have experienced fungal infections, such as histoplasmosis, blastomycosis and cocciioidmycosis.
In June 2008, the FDA released an early communication about an ongoing safety review involving Remicade and a possible association with the development of lymphoma and other cancers among children and young adults and a Remicade black box cancer warning was added in August 2009.
OVERVIEW: Remicade (infliximab) is an autoimmune disorder drug known as a Tumor Necrosis Factor (TNF) Blocker. It is approved by the FDA for treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis.
Unfortunately, many cases of fungal infections from Remicade go undiagnosed by doctors, since the symptoms are similar to the flu. Symptoms could include cough, fever, fatigue, loss of weight, sweating and shortness of breath.
It was the first TNF antagonist available in the United States, and has been used by more patients world-wide than the other medications in the same class, Enbrel and Humira, combined. It is a blockbuster drug for the pharmaceutical giant, Johnson & Johnson.
Remicade Lawsuits. The arthritis drug Remicade has been linked to a number of serious and potentially life threatening injuries. In September 2008, stronger warnings were added about an increased risk of invasive fungal infections.